Whitesmith Launches AI-Driven Health Solutions for Clinics
Whitesmith has introduced a groundbreaking AI health companion that empowers clinics to create customized digital health tools tailored for specific patient demographics. This innovation marks a significant milestone, demonstrating how advancements in artificial intelligence have reduced both economic and technical barriers that previously hindered the development of bespoke clinical software.
In a recent announcement from London and Coimbra, Portugal, the innovation studio revealed Methylation Coach AI, a fully operational AI health tool developed within four days—compared to the weeks or months typically required for such projects. This rapid development showcases how AI technology has effectively reduced the costs associated with creating specialized, evidence-based software for smaller healthcare providers.
Transforming Micro-Health Strategy
Rafael Jegundo, the CEO of Whitesmith, noted, “We can now build niche, clinically useful tools that were never commercially viable before. AI made the unit economics work.” He emphasized that the previous high opportunity costs are now mitigated, allowing for swift prototyping of tools that link genetic data with nutritional intake.
This shift enables the rise of “Micro-Health”—digital solutions designed not for vast populations but for targeted patient groups or even specific clinic clientele.
Enhancing Patient Care Beyond Appointments
The introduction of this technology also addresses a critical gap in patient care: the time between medical appointments. “Most health decisions occur between visits,” Jegundo explained. “With this technology, we anticipate more clinics creating ‘Concierge Apps’ that embody their specific care philosophies.” These apps will support patients’ health decisions when they’re not in consultation with healthcare professionals.
Ensuring Compliance with Synthetic Data
To mitigate concerns related to privacy and regulation, Whitesmith’s development process utilizes synthetic data. By employing generated patient profiles for prototyping, clinics can test their technical concepts and validate utility without facing immediate compliance challenges.
Methylation Coach AI operates using a large language model (LLM) that analyzes user-uploaded genetic data alongside nutritional logs integrated with Cronometer. This application provides real-time guidance on biochemical balance and is currently available on both iOS and Android platforms.
About Whitesmith
Based in London and Coimbra, Whitesmith is an innovation studio that offers fractional CTO services and AI transformation for various organizations, helping clients to turn emerging technologies into practical, user-centered solutions.
For further details, contact Mat Bennett at Whitesmith at 44 2392460000 or visit www.whitesmith.co.
